COMPANY

Astraea Therapeutics

HQ: Mountain View, CA source · astraeatherapeutics.com ↗ · West Coast

Also known as ASTRAEA THERAPEUTICS, LLC · 38 sources

Keywords: small molecule chronic pain

Location: Mountain View, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

38NIH grants

NIH awards 38

Annual award amounts. Total $26.2M.

Jun 26, 2024 NIH award 5UH3DA048371-05 FY2024: $869,673 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Next-genera source ↗
Apr 12, 2024 NIH award 3U01DA054882-03S1 FY2024: $99,995 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. First-in-Human Clinical D source ↗
Aug 18, 2023 NIH award 5UH3DA048371-04 FY2023: $2,183,507 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Next-gene source ↗
Apr 28, 2023 NIH award 5U01DA054882-03 FY2023: $1,398,808 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. First-in-Human Clinical source ↗
Aug 9, 2022 NIH award 4UH3DA048371-03 FY2022: $1,020,256 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Next-gene source ↗
May 10, 2022 NIH award 5U01DA054882-02 FY2022: $2,107,278 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. First-in-Human Clinical source ↗
Jul 16, 2021 NIH award 1U01DA054882-01 FY2021: $2,007,282 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. First-in-Human Clinical source ↗
Sep 15, 2020 NIH award 1U18DA052559-01 FY2020: $229,620 awarded for that fiscal year; activity U18 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. VALIDATING THE NOCICEPTIN source ↗
Jul 24, 2020 NIH award 5U01DA047791-03 FY2020: $646,565 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. DEVELOPMENT OF A NOVEL DRU source ↗
Dec 19, 2019 NIH award 5UG3DA048371-02 FY2020: $1,458,094 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Next-gene source ↗
Jul 30, 2019 NIH award 5U01DA047791-02 FY2019: $2,158,836 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. DEVELOPMENT OF A NOVEL D source ↗
Dec 26, 2018 NIH award 1UG3DA048371-01 FY2019: $1,458,094 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Next-gene source ↗
Sep 19, 2018 NIH award 1U01DA047791-01 FY2018: $1,141,152 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. DEVELOPMENT OF A NOVEL D source ↗
May 8, 2017 NIH award 5R44DA042465-03 FY2017: $736,013 awarded for that fiscal year; activity R44 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. A NOVEL APPROACH FOR PAIN TREAT source ↗
May 12, 2016 NIH award 3R44DA033744-03S1 FY2016: $5,000 awarded for that fiscal year; activity R44 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. PRECLINICAL DEVELOPMENT OF NOVE source ↗
May 6, 2016 NIH award 9R44DA042465-02 FY2016: $760,015 awarded for that fiscal year; activity R44 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. A NOVEL APPROACH FOR PAIN TREAT source ↗
May 6, 2015 NIH award 5R44DA033744-03 FY2015: $742,129 awarded for that fiscal year; activity R44 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. PRECLINICAL DEVELOPMENT OF NOVE source ↗
2015 NIH contract (government contract; not a grant and not an investment round) 275201500005C-0-0-1 FY2015: $999,993 awarded for that fiscal year; activity N44 (OTHER_NIH); PI ZAVERI, NURULAIN; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. De source ↗
May 14, 2014 NIH award 3R01DA027811-06S1 FY2014: $11,079 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗
May 13, 2014 NIH award 2R44DA033744-02 FY2014: $757,870 awarded for that fiscal year; activity R44 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. PRECLINICAL DEVELOPMENT OF NOVE source ↗
Feb 21, 2014 NIH award 5R01DA027811-06 FY2014: $709,446 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗
Aug 2, 2013 NIH award 5R01DA027811-05 FY2013: $703,039 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗
2013 NIH contract (government contract; not a grant and not an investment round) 275201300005C-0-0-1 FY2013: $297,170 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ZAVERI, NURULAIN; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. No source ↗
Aug 3, 2012 NIH award 5R01DA027811-04 FY2012: supplement or administrative line (under $1,000); activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional NOP/Op source ↗
Jul 28, 2012 NIH award 1R43HL115984-01 FY2012: $256,893 awarded for that fiscal year; activity R43 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Analgesic Potential of NOP Agon source ↗
May 23, 2012 NIH award 3R01DA027811-03S1 FY2012: $6,794 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗
Mar 30, 2012 NIH award 1R43DA033744-01 FY2012: $293,348 awarded for that fiscal year; activity R43 (SBIR); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Development of Novel Drugs for source ↗
Aug 3, 2011 NIH award 5R01DA027811-03 FY2011: $646,183 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗
Jul 11, 2011 NIH award 5R01DA014026-09 FY2011: $191,041 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. DISCOVERY OF SMALL-MOLECUL source ↗
May 31, 2011 NIH award 3R01DA027811-02S1 FY2011: $10,539 awarded for that fiscal year; activity R01 (OTHER_NIH); PI ZAVERI, NURULAIN T; recipient as written: ASTRAEA THERAPEUTICS, LLC, MOUNTAIN VIEW, CA. Discovery of Bifunctional source ↗